SELLAS Life Sciences Group Announces Closing of $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
March 19, 2024 16:05 ET
|
SELLAS Life Sciences Group, Inc.
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development...
Maxim Group Hires Tom Forte as Managing Director and Senior Consumer Internet Analyst
March 19, 2024 14:00 ET
|
Maxim Group LLC
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a leading full-service investment banking, securities and wealth management firm today announced that Tom Forte is re-joining the firm...
NM Holding, Nature’s Miracle and Lakeshore Acquisition II Corp. Announce Closing of Business Combination
March 11, 2024 16:10 ET
|
Nature’s Miracle Holding Inc.
Upland, CA, March 11, 2024 (GLOBE NEWSWIRE) -- Nature’s Miracle Holding Inc. (“the Company”), Nature’s Miracle, Inc. (“Nature’s Miracle”), a growing Controlled Environment Agriculture (CEA)...
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
March 11, 2024 08:30 ET
|
Aprea Therapeutics
Financing led by Sphera Healthcare with participation from new and existing healthcare-focused institutional investors $16.0 million in upfront gross proceeds with the potential to receive up to an...
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
March 04, 2024 08:31 ET
|
ReShape Lifesciences Inc
2024 Operating Expenses Expected to Decrease by 55.4% Compared to 2023 Company Reaffirms Commitment to Profitability High Priority Search for Synergistic M&A Partner Continues IRVINE,...
Aclarion Announces Closing of $3.0 Million Public Offering
February 27, 2024 15:22 ET
|
Aclarion, Inc.
BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers...
Draganfly Announces Closing of US$3.6 Million Underwritten Public Offering
February 26, 2024 16:15 ET
|
Draganfly Inc
Saskatoon, SK., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the...
Aclarion Announces Pricing of $3.0 Million Public Offering
February 26, 2024 09:15 ET
|
Aclarion, Inc.
BROOMFIELD, CO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging...
Draganfly Announces Pricing of US$3.6 Million Underwritten Public Offering
February 21, 2024 23:00 ET
|
Draganfly Inc
Saskatoon, SK., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the...
Draganfly Announces Proposed Public Offering of Common Shares & Warrants
February 21, 2024 16:05 ET
|
Draganfly Inc
Saskatoon, SK., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced it...